Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world.

A pioneer in the plasma industry, Grifols develops plasma-derived medicines and other innovative biopharmaceutical solutions that enable millions of patients with chronic and rare conditions to lead more productive lives.

As a recognized leader in transfusion medicine, we offer a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion, in addition to clinical diagnostic technologies. We provide high-quality biological supplies for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. In addition, the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care.

Grifols, with over 27,000 employees in more than 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry.

Grifols International, S.A.

Avinguda de la Generalitat, 152
Parc empresarial Can Sant Joan
08174 Sant Cugat del Vallès, Barcelona

Tel. +34 935712200
Fax +34 938008000


Notification of adverse reactions
To report an adverse drug reaction click here

Contact with Grifols

Type of consultation *
  • Others
  • Partnering
  • Product and commercial inquiries Bioscience
  • Product and commercial inquiries Diagnostic
  • Product and commercial inquiries Hospital
  • Technical support Diagnostic
  • Technical support Hospital

By clicking the button below, I declare being informed that my data is being used as described in the data protection information.

Data controller The Grifols’ group company to which you submit the request.
Purpose To manage your requests of information, suggestions and/or queries.
Legal basis Legitimate interest.
Recipients · Grifols’ group companies
· Other third parties
Rights To access, rectify and erase personal data, as well as other rights detailed in the additional information section.
Additional information For additional information on personal data protection check here.